Question 1

What is Tiago Reis Marques?

Accepted Answer

Tiago Reis Marques is a Person.

Question 2

How often does Tiago Reis Marques appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Tiago Reis Marques first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Tiago Reis Marques last mentioned in news?

Accepted Answer

Last active on Jun 02, 2026.

Question 5

What is Tiago Reis Marques's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Tiago Reis Marques in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Tiago Reis Marques?

Accepted Answer

Pasithea PAS-004 gets FDA Orphan Drug (Jun 02, 2026, 8 articles).

Question 8

How did the "Pasithea PAS-004 gets FDA Orphan Drug" event impact Tiago Reis Marques?

Accepted Answer

Tiago Reis Marques, CEO of Pasithea Therapeutics, commented on the significance of the Orphan Drug Designation for PAS-004 in addressing the unmet medical need for ALS.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.